Back to results
US 2004/0024038 A1Published application
GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity
AssigneeH. Lundbeck A/S
InventorsBjarke Ebert, Peter Hongaard Andersen
Life of this patent
Estimating the term…
Abstract
The invention provides the use of a non-steroid compound which acts on the GABA receptor for the treatment of disorders relating to reduced neurosteroid activity. The non-steroid compounds may be GABA agonists, GABA uptake inhibitors or enhancers of GABAergic activity.
Claims16
A method for treating a disease or disorder resulting from reduced neurosteroidal activation in a patient in need thereof, comprising administering to the patient a non-steroid compound which increases GABA activity in the brain.
Dependencies are inferred from the claim text.